New use of Chinese medicine compound pharmaceutical composition
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the field of traditional Chinese medicine compound pharmaceutical compositions, can solve the problems of inconvenience in clinical use, accurate medication, inconvenience for patients, etc., and achieve the effect of no effect on serum estrogen levels, delaying vaginal atrophy, and clear drug efficacy. Effect
Active Publication Date: 2011-06-08
CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Traditional Chinese medicine has traditional advantages in the treatment of senile diseases. However, for a disease that is accurately diagnosed by Western medicine standards, if there is no formally trained doctor, when clinically applying traditional Chinese medicine, it is often wrong to use it due to inaccurate syndrome differentiation, resulting in clinical symptoms. It is inconvenient to use, it is not convenient for accurate medication of the disease with exact diagnosis, and it also brings inconvenience and waste to patients
At present, there are no related reports about Zuogui Pills and Yougui Pills being used to delay vaginal atrophy
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0030] The preparation of embodiment 1 pharmaceutical composition 1 of the present invention (Zuogui pill)
[0032] Preparation method: The above eight flavors, except for antler glue and tortoise shell glue, the other six flavors such as rehmannia glutinosa are crushed into fine powder, sieved and mixed. Take deer horn glue and tortoise shell glue to melt, and mix with the above fine powder. For every 100g of powder, add 10g of refined honey and appropriate amount of water, make pills, and dry to obtain.
Embodiment 2
[0033] The preparation of embodiment 2 pharmaceutical composition 2 of the present invention (Yougui pill)
[0035] Preparation method: Steam the rehmannia glutinosa into a pestle paste, and make the rest into fine powder, add refined honey to make pills, which are as big as marbles. Take two or three pills (6 ~ 9g) every time you chew, and send it down with boiled soup.
Embodiment 3
[0036] Embodiment 3 preparation of medicine of the present invention
[0038] Preparation method: The above six flavors, except the antler gum, the other six flavors such as Rehmannia glutinosa are crushed into fine powder, sieved and mixed. Take the antler glue and melt it, and mix it with the above fine powder. Add 10g of refined honey and appropriate amount of water for every 100g of powder.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The present invention provides a medicine compound including the following raw materials with the weight portions such as 18 to 30 portions of prepared rehmannia rhizome, 9 to 12 portions of cornus dogwood fruit, 8 to 16 portions of Chinese yam, 9 to 12 portions of medlar, 8 to 16 portions of field dodder and 8 to 16 portions of deerhorn glue, and the purpose in preparing the medicine for delaying vaginal aging. The medicine is an active medicine for strengthening external gonad tissue aromatase and a medicine for increasing vaginal blood supply. The medicine is a medicine for preventing or / and curing senile vaginitis. Under a specific diagnosis standard, the medicine provided by the present invention has definite efficacy. The medicine has the advantages of same efficacy on delaying vaginal aging, few raw materials, wide sources, effective cost saving due to selection of raw materials, no effect on the level of serum estrogen after long-term administration, no proliferation on endometrium and safety. The present invention provides a new choice for clinically curing senile vaginitis, in particular preventing senile vaginitis or recurrence of senile vaginitis.
Description
technical field [0001] The invention relates to a new application of a traditional Chinese medicine compound pharmaceutical composition, in particular, an application in preparing a medicine for delaying vaginal atrophy. Background technique [0002] Estrogen mainly exists in two molecular forms: estrone (Estrone, E 1 ) and estradiol (Estradiol, E 2 ), E 1 and E 2 can be transformed into each other. due to E 1 The biological activity is only E 2 1% or so, so E 2 It is a physiologically significant estrogen molecule. The ovary of premenopausal non-pregnant women is the main organ for the synthesis of estrogen, which converts testosterone (Te) into E 2 ;Other sites can also synthesize a small amount of estrogen, including adipose tissue mesenchymal cells [1] , skin fibroblasts, osteoblasts, osteochondrocytes, cardiovascular endothelial cells and arterial smooth muscle cells. In addition, the preoptic area of the hypothalamus, the anterior part of the hypothalamus, t...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/8945A61P15/02A61K35/32
Inventor 陆华胡翔黄晓玲
Owner CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
Login to view more 
Login to view more